Catalyst Wire Dossier Catalyst Wire Dossier

ABT-874

briakinumab · AbbVie
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for ABT-874, covering 2011-08-23 to 2013-02-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]

See pricing